| 1 |
35175385 | Tau proteins in blood as biomarkers of Alzheimer's disease and other proteinopathies. | 2022 Feb |
1 |
| 2 |
34671305 | Prediction of Cerebral Amyloid Pathology Based on Plasma Amyloid and Tau Related Markers. | 2021 |
1 |
| 3 |
31704512 | Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease. | 2020 Jan 15 |
1 |
| 4 |
31780819 | Amyloid-β-independent regulators of tau pathology in Alzheimer disease. | 2020 Jan |
3 |
| 5 |
33224025 | The Interplay Between Beta-Amyloid 1-42 (Aβ1-42)-Induced Hippocampal Inflammatory Response, p-tau, Vascular Pathology, and Their Synergistic Contributions to Neuronal Death and Behavioral Deficits. | 2020 |
1 |
| 6 |
30540497 | Amelioration of amyloid β-FcγRIIb neurotoxicity and tau pathologies by targeting LYN. | 2019 Mar |
1 |
| 7 |
31260730 | Alzheimer's disease: Key developments support promising perspectives for therapy. | 2019 Aug |
1 |
| 8 |
30001606 | In vitro neuroprotective effects of naringenin nanoemulsion against β-amyloid toxicity through the regulation of amyloidogenesis and tau phosphorylation. | 2018 Oct 15 |
3 |
| 9 |
29168797 | Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models. | 2017 Nov 23 |
1 |
| 10 |
27676333 | Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease. | 2016 Dec |
1 |
| 11 |
25556849 | A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro. | 2015 May |
1 |
| 12 |
26637371 | The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. | 2015 Dec 4 |
2 |
| 13 |
23254634 | Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer's disease. | 2013 |
2 |
| 14 |
23627750 | On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease. | 2013 Jul |
1 |
| 15 |
22910909 | Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway. | 2012 Oct 12 |
2 |
| 16 |
20961659 | Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment. | 2011 Jan |
1 |
| 17 |
21715616 | Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities. | 2011 Jun 29 |
1 |
| 18 |
20136701 | Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation. | 2010 Apr |
1 |
| 19 |
20049742 | Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease. | 2009 Nov |
1 |
| 20 |
18031715 | Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3. | 2008 Jan 10 |
1 |
| 21 |
18289787 | Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection. | 2008 Mar 21 |
1 |
| 22 |
18322384 | Functional genomics dissects pathomechanisms in tauopathies: mitosis failure and unfolded protein response. | 2008 |
2 |
| 23 |
17420322 | Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia. | 2007 Apr |
1 |
| 24 |
14751770 | Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1. | 2004 Feb |
1 |
| 25 |
15505366 | Interaction of Alzheimer's disease amyloid beta peptide fragment 25-35 with tau protein, and with a tau peptide containing the microtubule binding domain. | 2004 Oct |
3 |
| 26 |
15644984 | Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. | 2004 Nov |
1 |